Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY

(HZNP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
All news about HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
01/11Horizon Therapeutics plc Submits Supplemental Biologics License for the Concomitant Use..
AQ
01/10Horizon Therapeutics Seeks to Expand Indication for Uncontrolled Gout Medicine Krystexx..
MT
01/10Horizon Therapeutics plc Submits Supplemental Biologics License for the Concomitant Use..
BU
01/062022 Could be a Banner Year for Biotech Stocks as per top managers (SPRC, HOTH, NLSP, P..
AQ
01/06Horizon Therapeutics plc Announces Significant Expansion of East Coast Research and Dev..
BU
01/06Horizon Therapeutics plc Announces Significant Expansion of East Coast Research and Dev..
CI
2021Horizon Therapeutics plc to Participate in Upcoming Investor Conferences
BU
2021Horizon Therapeutics Working With Alpine Immune Sciences to Develop Therapies for Autoi..
MT
2021HORIZON THERAPEUTICS PUBLIC LTD CO : Regulation FD Disclosure (form 8-K)
AQ
2021Alpine Immune Sciences and Horizon Therapeutics plc Announce Exclusive License and Coll..
BU
2021Alpine Immune Sciences, Inc. announced that it expects to receive $15 million in fundin..
CI
2021Wells Fargo Starts Horizon Therapeutics at Overweight With $137 Price Target
MT
2021INSIDER SELL : Horizon Therapeutics Public Ltd
MT
2021Horizon Therapeutics plc Makes $100,000 Seed Donation to Support Fundraising Efforts to..
AQ
2021Horizon Therapeutics plc Makes $100,000 Seed Donation to Support Fundraising Efforts to..
BU
2021Great Place to Work Names Horizon Therapeutics plc to Best Workplaces for Parents List
BU
2021INSIDER SELL : Horizon Therapeutics Public
MT
2021Horizon Therapeutics plc Provides Academic Scholarships to Help Economically Disadvanta..
BU
2021Horizon Therapeutics Says Phase 2/3 Data Support Efficacy of Uplizna in NMOSD Patients ..
MT
2021New Analysis Published in Multiple Sclerosis and Related Disorders Supports the Efficac..
BU
2021Horizon Therapeutics plc Announces That A New Post Hoc Analysis of the UPLIZNA N-Moment..
CI
2021Goldman Sachs Upgrades Horizon Therapeutics to Buy From Neutral; Price Target is $168
MT
2021Horizon Therapeutics plc Receives CHMP Positive Opinion for UPLIZNA (inebilizumab) as a..
AQ
2021Horizon Therapeutics plc - New Real-World Data Show High Rate of Patient Adherence to T..
AQ
2021Horizon Therapeutics Recognizes Second Annual Thyroid Eye Disease (TED) Awareness Week ..
BU
2021Horizon Therapeutics Says Data Show 'High Rate of Patient Adherence' to Tepezza for Thy..
MT
2021New Real-World Data Show High Rate of Patient Adherence to TEPEZZA« (teprotumumab-trbw)..
BU
2021Horizon Therapeutics plc announces findings of a real-world adherence analysis of TEPEZ..
CI
2021Horizon Therapeutics plc Receives CHMP Positive Opinion for UPLIZNA« (inebilizumab) as ..
BU
2021Horizon Therapeutics plc Receives CHMP Positive Opinion for UPLIZNA? (inebilizumab) as ..
CI
2021Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2b Pivotal Trial Eva..
BU
2021Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2B Pivotal Trial Eva..
CI
2021Horizon Therapeutics plc to Participate in Upcoming Investor Conferences
BU
2021Horizon Therapeutics plc Receives Top Workplace Awards in Chicago and San Francisco
AQ
2021INSIDER SELL : Horizon Therapeutics Public Ltd
MT
2021Horizon Therapeutics - Results from PROTECT Trial Evaluating KRYSTEXXA (pegloticase inj..
AQ
2021Horizon Therapeutics plc Receives Top Workplace Awards in Chicago and San Francisco
BU
2021Horizon Therapeutics Study of Krystexxa in Treatment of Gout in Kidney Transplant Patie..
MT
2021Results from PROTECT Trial Evaluating KRYSTEXXA« (pegloticase injection) in Kidney Tran..
BU
2021Horizon Therapeutics plc Announces the Presentation of Results from the Completed PROTE..
CI
2021INSIDER SELL : Horizon Therapeutics Public Ltd
MT
2021Horizon Therapeutics Public Limited Company Announces Management Changes
CI
2021Health Care Stocks Mixed Premarket Wednesday
MT
2021Horizon Therapeutics Q3 Adjusted Earnings, Net Sales Rise; Names New CFO
MT
2021HORIZON THERAPEUTICS : Q3 Earnings Snapshot
AQ
2021HORIZON THERAPEUTICS PUBLIC LTD CO MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL C..
AQ
2021Horizon Therapeutics plc Reports Record Third-Quarter 2021 Financial Results; Increasin..
PU
2021HORIZON THERAPEUTICS PUBLIC LTD CO : Results of Operations and Financial Condition, Change..
AQ
2021Horizon Therapeutics Public Limited Company Reports Earnings Results for the Third Quar..
CI
2021Earnings Flash (HZNP) HORIZON THERAPEUTICS Reports Q3 EPS $1.75, vs. Street Est of $1.5..
MT
2021Earnings Flash (HZNP) HORIZON THERAPEUTICS Reports Q3 Revenue $1.04B, vs. Street Est of..
MT
2021Horizon Therapeutics plc Announces Chief Financial Officer Succession Plan
BU
2021Horizon Therapeutics plc Reports Record Third-Quarter 2021 Financial Results; Increasin..
BU
2021Horizon Therapeutics plc Announces Chief Financial Officer Changes
CI
2021Horizon Therapeutics Public Limited Company Provides Earnings Guidance for the Full Yea..
CI
2021New Data Being Presented at American College of Rheumatology Convergence 2021 Highlight..
BU
2021Horizon Therapeutics plc Announces Presentations on Results from New Survey of Practici..
CI
2021Horizon Therapeutics - MIRROR Randomized Controlled Trial Meets Primary Endpoint and Sh..
AQ
2021HORIZON THERAPEUTICS PUBLIC : ' Gout Drug Trial Meets Primary Endpoint
MT
2021HORIZON THERAPEUTICS PUBLIC : MIRROR Randomized Controlled Trial Meets Primary Endpoint an..
BU
2021Horizon Therapeutics Public Limited Company Announces Mirror Randomized Controlled Tria..
CI
2021HORIZON THERAPEUTICS PUBLIC : plc Named to Newsweek's List of the Most Loved Workplaces fo..
AQ
2021HORIZON THERAPEUTICS PLC : Named to Newsweek's List of the Most Loved Workplaces for 2021
BU
2021HORIZON THERAPEUTICS PUBLIC : plc. - Newly Published Data Continue to Support Long-Term Ef..
AQ
2021HORIZON THERAPEUTICS PUBLIC : Says New Data Backing Thyroid Eye Disease Drug Long-Term Eff..
MT
2021HORIZON THERAPEUTICS PUBLIC : Newly Published Data Continue to Support Long-Term Efficacy ..
BU
2021Horizon Therapeutics plc Announces Additional Data Supporting the Long-Term Efficacy of..
CI
2021HORIZON THERAPEUTICS PUBLIC : plc - New Data Reinforce the Relationship Between B-Cell Dep..
AQ
2021HORIZON THERAPEUTICS PUBLIC : - New TEPEZZA (teprotumumab-trbw) Data to be Presented at th..
AQ
2021HORIZON THERAPEUTICS PUBLIC : New Data Reinforce the Relationship Between B-Cell Depletion..
BU
2021Horizon Therapeutics plc Announces Results from A New Analysis of the UPLIZNA Pivotal P..
CI
2021HORIZON THERAPEUTICS PUBLIC : New TEPEZZA« (teprotumumab-trbw) Data to be Presented at the..
BU
2021HORIZON THERAPEUTICS PLC : to Release Third-Quarter 2021 Financial Results and Host Webcas..
BU
2021HORIZON THERAPEUTICS PLC : Named One of the 2021 Top 100 Adoption-Friendly Workplaces by t..
BU
2021HORIZON THERAPEUTICS PUBLIC : plc - New Analysis Published in Multiple Sclerosis Journal A..
AQ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY